Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Disease Models & Mechanisms
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Disease Models & Mechanisms

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
RESEARCH ARTICLE
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects
Thomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, Farnoosh Khosrobakhsh, Laurent Jean Emorine, Gaëlle Friocourt, Pascale Belenguer, Marc Blondel, Laetitia Arnauné-Pelloquin
Disease Models & Mechanisms 2019 12: dmm036558 doi: 10.1242/dmm.036558 Published 7 February 2019
Thomas Delerue
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Déborah Tribouillard-Tanvier
2Institut National de la Santé et de la Recherche Médicale UMR1078, Université de Bretagne Occidentale, Etablissement Français du Sang Bretagne, CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, 29200 Brest, France
3Institut de Biochimie et Génétique Cellulaires, CNRS UMR 5095, Université de Bordeaux, 1 rue Camille Saint-Saëns, 33077 Bordeaux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Déborah Tribouillard-Tanvier
Marlène Daloyau
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farnoosh Khosrobakhsh
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Jean Emorine
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaëlle Friocourt
2Institut National de la Santé et de la Recherche Médicale UMR1078, Université de Bretagne Occidentale, Etablissement Français du Sang Bretagne, CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, 29200 Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Belenguer
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pascale Belenguer
  • For correspondence: pascale.belenguer@univ-tlse3.fr
Marc Blondel
2Institut National de la Santé et de la Recherche Médicale UMR1078, Université de Bretagne Occidentale, Etablissement Français du Sang Bretagne, CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, 29200 Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Blondel
Laetitia Arnauné-Pelloquin
1Research Center on Animal Cognition (CRCA) and Center of Developmental Biology (CBD), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, 118 route de Narbonne, 31062 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    The P300S thermosensitive mutation in the GTPase domain of Mps1p is lethal for the yeast S. pombe grown at restrictive temperature in a galactose-based medium. (A) Schematic representation of the Msp1p protein and its domains: mitochondrial import sequence (MIS), transmembrane domains (TM1 and TM2), catalytic domain (GTPase), central domain (Middle) and GTPase effector domain (GED). The thermosensitive mutant contains at position 300 a serine residue instead of a proline residue (P300S). (B) Drops, each containing 800 cells of the msp1WT or msp1P300S strains, were deposited onto solid agar-based medium containing dextrose (dex) or galactose (gal). The plates were then incubated at 25°C or 37°C for 3 days and photographed. (C) msp1WT or mutant msp1P300S strains expressing a version of the mitochondrial protein Arg11p fused to the fluorescent mCherry protein (Arg11p-mCherry) were grown at 37°C for 18 h in galactose liquid medium, fixed and labeled with DAPI before visualization by fluorescence microscopy. Scale bar: 5 µm. High magnifications are shown in insets (×1.7). B and C are representative of five independent experiments. (D) The numbers of mitochondrial nucleoids, visualized as bright dots scattered throughout the cytoplasm in fluorescence microscopy after DAPI staining, were counted in the msp1WT and msp1P300S strains cultured at 37°C in galactose liquid medium for 18 h. Data represent the mean±s.d. of three independent experiments, with 50 cells per condition, and were statistically analyzed using a two-tailed unpaired Student's t-test (****P<0.0001).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Drug screening to isolate pharmacological suppressors of lethality of an msp1P300S strain grown at restrictive temperature in a galactose-based medium. (A) Experimental strategy: a yeast strain expressing a thermosensitive form of the Msp1p protein (msp1P300S) was grown at the permissive temperature (25°C) and then spread on agar-based solid medium containing galactose. Then, filters were deposited onto the agar surface and individually loaded with single pharmacological compounds from repurposed drug libraries (3 µl at 10 mM or DMSO as a control onto the top left filter) and Petri plates were then incubated at the restrictive temperature (37°C) for 5-7 days and photographed. (B) The presence of a white halo around the filter indicates yeast growth. The presence of a dark halo indicates the absence of growth and therefore toxicity of the compound at high concentration (close to the filter). The names of the compounds and their chemical structures are indicated. The indicated quantities of drugs were added onto the filters. (C) Drops containing 800 cells expressing WT (msp1WT) or thermosensitive (msp1P300S) Msp1p protein were deposited on agar-based solid medium containing either galactose (gal) without (-) or with 6 μM vanoxerine, 30 μM hexestrol, 15 μM clomifene, 1 μM ketoconazole or 9 μM terconazole, or dextrose (dex) without (-) or with 1 μM vanoxerine, 10 μM hexestrol, 15 μM clomifene, 1 μM ketoconazole or 1 μM terconazole, as indicated. The plates were then incubated at 37°C for 3 days and photographed. C is representative of three independent experiments.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effects of hexestrol and clomifene on mitochondrial morphology and maintenance of mtDNA. (A,B) Yeasts expressing the mitochondrial protein Arg11p fused to the fluorescent mCherry protein (Arg11p-mCherry), together with either WT (strain msp1WT) or mutated (strain msp1P300S) Msp1p protein, were cultured at 37°C for 18 h on dextrose liquid medium, without (-) or with 15 μM hexestrol (Hex) or 4 μM clomifene (Clo) as indicated, and then fixed and labeled with DAPI before being observed with a fluorescence microscope. Scale bar: 5 μm. High magnifications are shown in insets (×1.7). A and B are representative of five experiments. (C) The number of mitochondrial nucleoids was counted in the msp1WT and msp1P300S strains cultured at 37°C in dextrose liquid medium for 18 h without (-) or with 15 μM hexestrol (Hex) or 4 μM clomifene (Clo), as indicated. Data represent the mean±s.d. of two independent experiments with 50 cells per condition. They were statistically analyzed using Kruskal–Wallis Dunn's multiple comparison tests to compare, for each strain, the values obtained with drugs (Hex, Clo) with that obtained for the control (-) (****P<0.0001). (D) qPCR was performed on DNA extracted from the msp1WT and msp1P300S strains cultured at 37°C on dextrose liquid medium for 18 h without (-) or with 15 μM hexestrol (Hex) or 4 μM clomifene (Clo), as indicated. The results of three independent experiments performed in triplicate are expressed as a percentage relative to those obtained for the msp1WT strain cultured at 37°C (Student's t-tests; **P<0.01; ***P<0.001).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Mechanisms of action of hexestrol and clomifene. (A) Yeast strains of the indicated genotypes (Table 1) were cultured on dextrose minimal medium without (-) or with 50 μM hexestrol (Hex) or 15 μM clomifene (Clo) at 25°C for 6 days and then photographed. Top panel: strains with deletions of msp1+ (Δmsp1+) ectopically expressing msp1+, or not, under the control of the nmt1 promoter. Msp1p is produced in the absence of thiamine (Msp1p), but not in its presence (no Msp1p). Middle panel: WT strains ectopically overexpressing a WT form of msp1+, or a form containing a mutated GED domain, under the control of the nmt1+ promoter. WT Msp1p (OP Msp1p), Msp1p with the L876P mutation (OP Msp1pL876P) or Msp1p with a deletion of the last 50 amino acids of the protein (OP Msp1pΔGED) were overexpressed in the absence of thiamine. Bottom panel: strains with deletions of fzo1+ (Δfzo1+) ectopically expressing fzo1+ under the control of the nmt1+ promoter. Fzo1p (Fzo1p) is produced in the absence of thiamine, whereas it is not expressed (no Fzo1p) in its presence. (B) Yeasts with deletion of msp1+ (Δmsp1+) expressing the mitochondrial protein Arg11p fused to the fluorescent mCherry protein (Arg11p-mCherry), for which the ectopic expression of msp1+ was abolished by addition of thiamine (no Msp1p), were cultured at 25°C in dextrose minimal liquid medium for 72 h with or without 50 μM hexestrol (Hex), and stained with DAPI before observation under a fluorescence microscope. Left column: representative pictures of Arg11p-mCherry and DAPI staining. Scale bar: 5 μm. High magnifications are shown in insets (×1.7). Right column: the number of mitochondrial nucleoids was counted in yeasts with deletion of msp1+ (Δmsp1+) cultured at 25°C in dextrose liquid medium for 72 h with thiamine (no Mps1p) and without (-) or with 50 μM hexestrol (Hex). Data represent the mean±s.d. of three independent experiments, with 60 cells per condition, and were statistically analyzed by a two-tailed unpaired Mann–Whitney test (***P<0.001). (C) A WT strain and a strain deleted for the dnm1+ gene (Δdnm1+), expressing the mitochondrial protein Arg11p fused to the fluorescent mCherry protein (Arg11p-mCherry) were cultured in dextrose liquid medium at 25°C with or without 15 μM hexestrol (Hex) for 18 h as indicated. Sodium azide (Azide) was then added to a final concentration of 0.02% w/v, the cultures were incubated for 30 min, and the cells were fixed and observed by fluorescence microscopy. Scale bar: 5 μm. High magnifications are shown in insets (×1.7). A, B and C are representative of three experiments.

  • Table 1.
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Mitochondrial fusion
  • Mitochondrial DNA
  • Hexestrol
  • Clomifene
  • Yeast
  • OPA1

 Download PDF

Email

Thank you for your interest in spreading the word on Disease Models & Mechanisms.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects
(Your Name) has sent you a message from Disease Models & Mechanisms
(Your Name) thought you would like to see the Disease Models & Mechanisms web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
RESEARCH ARTICLE
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects
Thomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, Farnoosh Khosrobakhsh, Laurent Jean Emorine, Gaëlle Friocourt, Pascale Belenguer, Marc Blondel, Laetitia Arnauné-Pelloquin
Disease Models & Mechanisms 2019 12: dmm036558 doi: 10.1242/dmm.036558 Published 7 February 2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
RESEARCH ARTICLE
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects
Thomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, Farnoosh Khosrobakhsh, Laurent Jean Emorine, Gaëlle Friocourt, Pascale Belenguer, Marc Blondel, Laetitia Arnauné-Pelloquin
Disease Models & Mechanisms 2019 12: dmm036558 doi: 10.1242/dmm.036558 Published 7 February 2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression
  • Altered cytoskeletal arrangement in induced pluripotent stem cells and motor neurons from patients with riboflavin transporter deficiency
  • Cardiovascular phenotype of the Dmdmdx rat – a suitable animal model for Duchenne muscular dystrophy
Show more RESEARCH ARTICLE

Similar articles

Subject collections

  • Rare diseases
  • Model Systems in Drug Discovery

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Biology Open

Advertisement

DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


Monica Justice bids farewell to DMM

In her farewell Editorial, outgoing Editor-in-Chief Monica Justice reminds us of the past half-decade of growth and of DMM's commitment to support the disease modelling community, concluding, “The knowledge and experience I gained during my time as Senior Editor and EiC at DMM is invaluable: working within a not-for-profit community publishing environment is a joy.”


3D imaging of beta cell mass in diabetic mouse models

In their inducible mouse model of diabetes, Roostalu et al. demonstrate how quantitative light-sheet imaging can capture changes in individual islets to help pharmacological research in diabetes.

Visit our YouTube channel to watch more videos from DMM, our sister journals and the Company.


Modelling Joubert syndrome patient-derived mutations in C. elegans

In this issue’s Editor’s choice, Karen Lange and colleagues used C. elegans to model and characterise two patient-derived mutations that cause the ciliopathy Joubert syndrome.


Interview – Karen Lange

First author of our current Editor’s choice, Karen Lange takes us behind the scenes of the paper, and shares her thoughts on how the lack of both time and job security will impact her research.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About DMM
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact DMM
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992